Cargando…
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express polymorphic clonotypic receptors and utilize inhibitory receptors (killer immunoglobulin-like recept...
Autores principales: | Abel, Alex M., Yang, Chao, Thakar, Monica S., Malarkannan, Subramaniam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099181/ https://www.ncbi.nlm.nih.gov/pubmed/30150991 http://dx.doi.org/10.3389/fimmu.2018.01869 |
Ejemplares similares
-
mTORC1 and mTORC2 differentially promote natural killer cell development
por: Yang, Chao, et al.
Publicado: (2018) -
The Fyn–ADAP Axis: Cytotoxicity Versus Cytokine Production in Killer Cells
por: Gerbec, Zachary J., et al.
Publicado: (2015) -
Clinical Relevance of Natural Killer Cells Following Hematopoietic Stem Cell Transplantation
por: Palmer, Jeanne M, et al.
Publicado: (2012) -
IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells
por: Abel, Alex M., et al.
Publicado: (2018) -
Transcriptional Regulation of Natural Killer Cell Development and Functions
por: Wang, Dandan, et al.
Publicado: (2020)